GGrantIndex
Sort

64,565 grants matching drug discovery

GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease

$1,546,977
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2022 · AG

GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease

$1,546,636
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2024 · AG

SBIR Phase II: Quantitative Phase Imaging for Life Sciences

$1,546,326
Catalin Chiritescu · Phi Optics Inc. · · FY2014 · TIP

Microbial Chemical Sensing and Host Responses

$1,546,305
Jason Michael Crawford · Yale University · RM1 · FY2024 · GM

Enhancement of Cancer Research at Clark Atlanta University

$1,546,132
Daqing Wu · Clark Atlanta University · U54 · FY2022 · MD

Microbial Chemical Sensing and Host Responses

$1,545,830
Jason Michael Crawford · Yale University · RM1 · FY2023 · GM

Microbial Chemical Sensing and Host Responses

$1,545,370
Jason Michael Crawford · Yale University · RM1 · FY2022 · GM

Yale/NIDA Neuroproteomics Center

$1,544,774
Kenneth Robert Williams · Yale University · P30 · FY2018 · DA

Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease

$1,544,773
Catherine Cook Kaczorowski · University Of Michigan At Ann Arbor · R01 · FY2024 · AG

Cancer Center Support Grant (CORE) Renewal

$1,544,675
Timothy L Ratliff · Purdue University · P30 · FY2017 · CA

Metabolic Networks and Pathways in Alzheimer's Disease

$1,544,530
Rima F Kaddurah-Daouk · Duke University · R01 · FY2016 · AG

PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial

$1,544,481
Roberta Diaz Brinton · University Of Arizona · R01 · FY2023 · AG

Telomere Biology

$1,544,438
Julia Cooper · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Microbial Chemical Sensing and Host Responses

$1,543,904
Jason Michael Crawford · Yale University · RM1 · FY2021 · GM

A Quantitative Proteomics Platform to Characterize the Nicotine-Dependent Brain

$1,543,823
Benjamin F Cravatt · Scripps Research Institute, The · RC2 · FY2009 · DA

TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)

$1,543,781
Payam Nahid · University Of California, San Francisco · R01 · FY2013 · AI

Medicinal Chemistry and Lead Development Core

$1,543,290
Joseph A Maddry · University Of Alabama At Birmingham · U19 · FY2015 · AI

Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities

$1,542,983
Gary Matthew Hunninghake · Brigham And Women'S Hospital · R01 · FY2025 · HL

PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials

$1,542,450
Zeynep Hulya Gumus · Icahn School Of Medicine At Mount Sinai · R33 · FY2021 · CA

Defining RAS isoform- and mutation-specific roles in oncogenesis

$1,542,424
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2017 · CA

Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease

$1,541,709
Allan I Levey · Emory University · U01 · FY2016 · AG

Novel Therapeutics for FSHD

$1,541,442
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2022 · HD

Novel Therapeutics for FSHD

$1,541,442
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2021 · HD

Novel Therapeutics for FSHD

$1,541,442
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2020 · HD

Probing Tumor Microenvironment Using Nanotechnology

$1,541,419
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2011 · CA